Literature DB >> 27101095

Enhanced Soluble Serum CD40L and Serum P-Selectin Levels in Primary Aldosteronism.

L Petramala1, G Iacobellis2, R Carnevale3, C Marinelli1, L Zinnamosca1, A Concistrè1, M Galassi1, G Iannucci1, P Lucia1, P Pignatelli3, A Ciardi4, F Violi3, G De Toma4, C Letizia1.   

Abstract

Primary aldosteronism (PA) is one of the most frequent forms of secondary hypertension, associated with atherosclerosis and higher risk of cardiovascular events. Platelets play a key role in the atherosclerotic process. The aim of the study was to evaluate the platelet activation by measuring serum levels of soluble CD40L (sCD40L) and P-selectin (sP-selectin) in consecutive PA patients [subgroup: aldosterone-secreting adrenal adenoma (APA) and bilateral adrenal hyperplasia (IHA)], matched with essential hypertensive (EH) patients. The subgroup of APA patients was revaluated 6-months after unilateral adrenalectomy. In all PA group, we measured higher serum levels of both sP-selectin (14.29±9.33 pg/ml) and sCD40L (9.53±4.2 ng/ml) compared to EH patients (9.39±5.3 pg/ml and 3.54±0.94 ng/ml, respectively; p<0.001). After removal of APA, PA patients showed significant reduction of blood pressure (BP) values, plasma aldosterone (PAC) levels and ARR-ratio, associated with a significant reduction of sP-selectin (16.74±8.9 pg/ml vs. 8.1±3.8 pg/ml; p<0.01) and sCD40L (8.6±1 ng/ml vs. 5.24±0.94 ng/ml; p<0.001). In PA patients, we found a significant correlation between sP-selectin and sCD40L with PAC (r=0.52, p<0.01; r=0.50, p<0.01, respectively); this correlation was stronger in APA patients (r=0.54; p<0.01 r=0.63; p<0.01, respectively). Our results showed that PA is related to platelet activation, expressed as higher plasma values of sCD40L and sP-selectin values. Surgical treatment and consequent normalization of aldosterone secretion was associated with significant reduction of sCD40L and sP-selectin values in APA patients. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27101095     DOI: 10.1055/s-0042-103588

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  8 in total

1.  Evaluation of Intra-Renal Stiffness in Patients with Primary Aldosteronism.

Authors:  Luigi Petramala; Antonio Concistrè; Francesco Circosta; Antonietta Gigante; Francesca Sarlo; Mauro Schina; Maurizio Soldini; Gino Iannucci; Rosario Cianci; Claudio Letizia
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-11-10

2.  Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study.

Authors:  Jan K Nowak; Irena Wojsyk-Banaszak; Edyta Mądry; Andrzej Wykrętowicz; Patrycja Krzyżanowska; Sławomira Drzymała-Czyż; Agata Nowicka; Andrzej Pogorzelski; Ewa Sapiejka; Wojciech Skorupa; Mariusz Szczepanik; Aleksandra Lisowska; Jaroslaw Walkowiak
Journal:  Lung       Date:  2017-06-23       Impact factor: 2.584

3.  Predicting factors related with uncured hypertension after retroperitoneal laparoscopic adrenalectomy for unilateral primary aldosteronism.

Authors:  WuYun BiLiGe; Chaoqi Wang; JiRiGaLa Bao; Dahai Yu; A Min; Zhi Hong; Xiangbao Chen; Min Wang; Dongmei Wang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  Analysis of the miRNA expression from the adipose tissue surrounding the adrenal neoplasia.

Authors:  Antonio Concistrè; Luigi Petramala; Francesco Circosta; Priscilla Romagnoli; Maurizio Soldini; Marco Bucci; Domenico De Cesare; Giuseppe Cavallaro; Giorgio De Toma; Francesco Cipollone; Claudio Letizia
Journal:  Front Cardiovasc Med       Date:  2022-07-28

5.  Relationship between plasma aldosterone levels and arterial stiffness parameters in hypertensive patients with subclinical vascular damage.

Authors:  L Petramala; A Concistrè; M Mezzadri; F Sarlo; F Circosta; M Schina; M Soldini; G Iannucci; C Letizia
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2022-06-06

6.  Association of Papillary Thyroid Carcinoma with Primary Aldosteronism.

Authors:  Shigenori Nakamura; Masatoshi Ishimori; Noriyoshi Yamakita
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

7.  Clinical impacts of endothelium-dependent flow-mediated vasodilation assessment on primary aldosteronism.

Authors:  Daisuke Watanabe; Satoshi Morimoto; Noriko Morishima; Atsuhiro Ichihara
Journal:  Endocr Connect       Date:  2021-06-08       Impact factor: 3.335

8.  Cardiovascular events and all-cause mortality in surgically or medically treated primary aldosteronism: A Meta-analysis.

Authors:  Ying Jing; Kangla Liao; Ruolin Li; Shumin Yang; Ying Song; Wenwen He; Kanran Wang; Jun Yang; Qifu Li; Jinbo Hu
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021 Jan-Dec       Impact factor: 1.636

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.